Candel Therapeutics Aktie
WKN DE: A3CVW2 / ISIN: US1374041093
23.06.2025 15:25:11
|
Candel Names Charles Schoch CFO
(RTTNews) - Candel Therapeutics, Inc.(CADL), a clinical-stage biopharmaceutical company, on Monday announced the appointment of Charles Schoch as Chief Financial Officer, with an immediate effect.
Schoch joined the company in Novemeber 2021 and has served as interim CFO since January 2024, will now transition to the CFO role permanently.
Prior to joining Candel, Schoch served as Corporate Controller at Corbus Pharmaceuticals since 2019.
On Friday, Candel closed trading 3.46% lesser at $4.75 on the Nasdaq.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Candel Therapeutics Inc Registered Shsmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Candel Therapeutics Inc Registered Shsmehr Analysen
Aktien in diesem Artikel
Candel Therapeutics Inc Registered Shs | 5,26 | -3,13% |
|